SCHEMBL15326809

SCHEMBL15326809

CCn1cc(C(F)(F)F)nn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMPD1 P17405 4/20 0.38
▸ AR P10275 1/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ RET P07949 1/20 0.33
▸ GABRA2 P47869 2/20 0.33
▸ GABRB2 P47870 2/20 0.33
▸ CCNK O75909 1/20 0.33
▸ CDK12 Q9NYV4 1/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ ALOX5 P09917 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ KDM5C P41229 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32
▸ KDM2A Q9Y2K7 1/20 0.32
▸ KDM3A Q9Y4C1 1/20 0.32
▸ MDM4 O15151 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MDM2 Q00987 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12432229 0.81 HRH4 (0.46) SMPD1DPP4RETGABRA2GABRB2
SCHEMBL19723261 0.78 SMPD1 (0.37) SMPD1DPP4RETCCNKCDK12
SCHEMBL16264805 0.78 AR (0.42) SMPD1ARDPP4RETHRH4
SCHEMBL13888914 0.78 HRH4 (0.38) SMPD1DPP4RETCCNKCDK12
SCHEMBL14420994 0.76 SMPD1 (0.40) SMPD1RETCCNKCDK12HRH4
SCHEMBL25155024 0.75 SMPD1 (0.42) SMPD1DPP4RETCCNKCDK12
SCHEMBL18595057 0.75 SMPD1 (0.39) SMPD1DPP4RETCCNKCDK12
SCHEMBL25624227 0.75 SMPD1 (0.36) SMPD1DPP4RETCCNKCDK12
SCHEMBL16264806 0.75 SMPD1 (0.36) SMPD1DPP4RETCCNKCDK12
SCHEMBL16584161 0.75 MAPK1 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2834238-B1 DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS PFIZER (US) 2017-02-01 — — EP disclosed
US-9296745-B2 Diacylglycerol acyltransferase 2 inhibitors PFIZER INC. (US) 2016-03-29 — — US disclosed
US-20150087585-A1 DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS PFIZER INC. (US) 2015-03-26 — — US disclosed
WO-2013150416-A1 DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS PFIZER INC. (US) 2013-10-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150087585-A1 DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS DGAT2, DGAT1, PLAAT2 SMPD1 132/4885AR 4551/4885DPP4 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback